← Back to Search

Behavioural Intervention

Digital Well-Being Program for Healthcare Workers' Mental Health (Thrive Trial)

N/A

Waitlist Available

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at month 18

Awards & highlights

Thrive Trial Summary

This trial aims to evaluate the effectiveness of a digital wellbeing program to improve mental health and well-being of physicians, and create a culture of support during the pandemic.

Who is the study for?

This trial is for physicians at Penn Medicine who are over 18, willing to join an 18-month study with regular surveys, and have daily access to a phone capable of texting. It's not open to those under 18 or anyone unwilling to consent or without the necessary phone access.Check my eligibility

What is being tested?

The trial tests a digital well-being program aimed at improving mental health and job satisfaction among doctors during COVID. It involves interviews, text messages, resource support, and peer groups compared against usual care in a randomized controlled setup.See study design

What are the potential side effects?

Since this is a non-medical intervention focusing on well-being through digital means, traditional side effects like those seen with medications are not expected. However, participants may experience varying levels of engagement or stress relief.

Thrive Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at month 18

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at month 18

This trial's timeline: 3 weeks for screening, Varies for treatment, and at month 18 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Well-Being Index (WBI)

Secondary outcome measures

Connor-Davidson Resilience Scale (CDRS)

General Anxiety Disorder (GAD-2)

Patient Health Questionnaire (PHQ-2)

+3 more

Thrive Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Comprehensive Well-Being InterventionExperimental Treatment1 Intervention

Participants will be asked to complete an ICF and baseline survey at enrollment. Participants will complete a full assessment using validated instruments at enrollment, 18 months and 30 months (depression, anxiety, stress, resilience, and job satisfaction). Participants will also complete the brief well-being index (WBI, nine questions) every 3 months over 30 months. The primary endpoint is assessed at 18 months. A secondary endpoint of persistence of effect is measured at 30 months. The intervention group will receive an 18-month comprehensive suite of services including: 1) monthly automated text messaging reminders about wellbeing resources focused on a range of topics (e.g. mindfulness, stress management, childcare support, racial trauma, diversity and inclusion) and assignment to a one-hour quarterly peer support group with an expectation of regular attendance. Half of these sessions will be self-directed discussion topics and half will be facilitated discussions.

Group II: Usual CareActive Control1 Intervention

Participants will be asked to complete an ICF and baseline survey at enrollment. They will be given survey assessments at 0, 18 and 30 months. Survey assessments will include validated measures on well-being, depression, anxiety, stress, resilience, and job satisfaction of physicians. The control group will have access to usual care well-being resources at Penn Medicine. These include links, classes, groups, social media sites such as Penn Cobalt which require self-awareness to find the resources and access them. In this context, the individual has to "pull" the resources they need and there may be several barriers to completing each step

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,881,994 Total Patients Enrolled

Pennsylvania Department of HealthOTHER_GOV

41 Previous Clinical Trials

998,102 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants being welcomed to this clinical experiment?

"Affirmative. According to records on clinicaltrials.gov, this trial is currently in the process of enrolling patients who meet its requirements, with 300 subjects needed from a single site. The study was first posted on September 27th 2023 and last updated one day later."

Answered by AI

What is the aggregate quantity of participants joining this experiment?

"Affirmative. According to information found on clinicaltrials.gov, this medical trial is recruiting participants as of now. This investigation was initially posted on September 27th 2023 and has been recently updated on the 26th of that same month. The study requires 300 individuals from a single site in order to be successful"

Answered by AI